Tag Archives: PBMD

Wednesday’s Highlights at Noon: TCP International (TCPI), EKSO BIONICS (EKSO), Synthetic Biologics Inc (SYN), Prima Biomed (PBMD), Palatin Technologies (PTN)

So far Wednesday, November 22, NASDAQ is down -0.41% and the S&P is down -0.33%. Let’s take a look at this morning’s most active stocks and their recent analyst insights; TCP International (NYSE:TCPI), EKSO BIONICS (NASDAQ:EKSO), Synthetic Biologics Inc (NYSE

Prima Biomed Receives a Buy from Maxim Group

Maxim Group analyst Jason McCarthy assigned a Buy rating to Prima Biomed (NASDAQ: PBMD) today and set a price target of $7. The company’s shares opened today at $2.30. McCarthy said: “Prima announced data that will be presented at the

Maxim Group Reaffirms Their Buy Rating on Prima Biomed

Maxim Group analyst Jason McCarthy reiterated a Buy rating on Prima Biomed (NASDAQ: PBMD) today and set a price target of $7. The company’s shares opened today at $1.77. McCarthy commented: “Prima updated the company’s financial position, reporting $10M in

Maxim Group Sticks to Their Buy Rating for Prima Biomed

Maxim Group analyst Jason McCarthy reiterated a Buy rating on Prima Biomed (NASDAQ: PBMD) today and set a price target of $7. The company’s shares closed last Friday at $2.56. McCarthy noted: “Prima announced positive safety and early efficacy data

Analysts’ Top Healthcare Picks: PBMD, NK

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Prima Biomed (NASDAQ: PBMD) and NantKwest (NASDAQ: NK) with bullish sentiments. Prima Biomed (NASDAQ: PBMD) In a report released today, Vernon Bernardino

Thursday’s Midday Stock Update: OvaScience (OVAS), Prima Biomed (PBMD), Tokai Pharma (TKAI), Lpath (LPTN), Magellan Petroleum Corp. (MPET)

So far Thursday, December 22, NASDAQ is down -1.11% and the S&P is down -0.6%. Let’s take a look at this morning’s most active stocks and their recent analyst insights; OvaScience (NASDAQ:OVAS), Prima Biomed (NASDAQ:PBMD), Tokai Pharma (NASDAQ:TKAI), Lpath (NASDAQ:LPTN)